Up 25% In A Month, Will Corcept Therapeutics Stock Continue Its Upward Trajectory?

The stock price of Corcept Therapeutics (NASDAQ: CORT), a relatively small pharmaceuticals company with a market capitalization of $2.6 billion, focused on the treatment of severe metabolic, oncologic, and neuropsychiatric disorders, has seen a substantial rise of 25% in a month, while it is up 1...